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We aimed to evaluate the eﬀectiveness of the application of an atelocollagen matrix containing autologous adipose tissue-derived
stromal cells (ASCs) on wound healing in diabetic (db/db) mice. Cultured ASCs from db/db mice and from db/+ mice secreted
identical amounts of growth factors, cytokines, and type I collagen. ASCs from db/db mice proliferated at the same rate as
those from db/+ mice. When DiI-labeled ASCs were applied to full-thickness round skin wounds on the backs of diabetic db/db
mice, histological observation at 2 weeks showed that red ﬂuorescent-labeled tissues were formed in the epidermis, dermis, and
capillaries. Twelve db/db mice were treated with either matrix alone or matrix containing ASCs and then sacriﬁced at 1 or 2
weeks. A histological examination demonstrated signiﬁcantly advanced granulation tissue formation, capillary formation, and
epithelialization in those wounds treated with atelocollagen matrix containing ASCs, compared with wounds treated with matrix
alone.
1.Introduction
Although many tissues are known to contain lineage-
committed progenitor cells for tissue maintenance and
repair, severalstudieshave also demonstrated thepresence of
uncommitted progenitor cells within the matrix of connec-
tive tissues [1]. For instance, human adipose tissue-derived
multilineage(stromal) cellshavethepotentialtodiﬀerentiate
into bone [2], cartilage [3], fat [4], myocardium [5], skin
[6], skeletal muscle [7], and neurons [8, 9]. No signiﬁcant
diﬀerences have been observed between adipose tissue-
derived stromal cells (ASCs) and human bone marrow-
derived mesenchymal stem cells from the same patient
with regard to yield of adherent cells, growth kinetics, cell
senescence, diﬀerentiation capacity, or gene transduction
eﬃciency [10]. Furthermore, transplantation of constructs
cultured with human ASCs signiﬁcantly stimulates skin
repair, angiogenesis, and re-epithelialization in athymic
mice when compared with constructs cultured with human
ﬁbroblasts [11]. The multipotent characteristics of ASCs, as
well as their abundance in the human body, make ASCs a
potential resource for wound repair and tissue engineering
applications.
Woundhealingproceedsin3overlappingphases:inﬂam-
mation, proliferation (including formation of granulation
tissue), and matrix formation and remodeling [12]. This
sequential process requires the interaction of cells in the
dermis and epidermis as well as the activity of chemical
mediators released from inﬂammatory cells, ﬁbroblasts, and
keratinocytes [12]. An absence of the cellular and molec-
ular signals required for normal wound repair processes—
such as inﬂammation, angiogenesis, contraction, deposi-
tion of extracellular matrix, granulation tissue formation,2 Journal of Tissue Engineering
epithelialization, and remodeling—may contribute to poor
healing of some wounds, such as diabetic ulcers [12–14].
Numerous strategies have been investigated for coverage
of such skin defects, including temporary skin substitutes
(porcine xenografts, synthetic membranes, atelocollagen
sponge, and allogenic substitutes) and permanent skin sub-
stitutes(culturedepidermisand dermal substitutes) [15, 16].
Artiﬁcial dermal substitutes, such as atelocollagen matrix
(ACM; PELNAC; Johnson & Johnson Japan, Tokyo, Japan),
are structurally optimized to incorporate into surrounding
tissue and to allow cell invasion by ﬁbroblasts and capillaries
for subsequent dermal remodeling [16, 17]. Nevertheless,
eﬀective coverage is still not established when the area to
be covered is large or the local conditions are poor—as in
cases of severe contamination, very poor blood ﬂow and
vascularity, or congenital skin disorders like epidermolysis
bullosa [16, 18].
A previous wound healing study using a mitomycin C-
treated, healing-impaired rat model showed that the applica-
tionofanACMcontaininginbredASCsontoanopenwound
signiﬁcantly induced the formation of granulation tissue
and capillaries and accelerated wound healing [19]. The
eﬀectiveness of ACM containing autologous ASCs has been
evaluated using full-thickness skin incisions on the backs
of healing-impaired diabetic (db/db)m i c e[ 20]. The present
study demonstrated that cultured ASCs from db/db mice
proliferated well, secreted substantial amounts of growth
factors and cytokines, and generated type I collagen, all
of which are suitable for wound repair. Furthermore, the
majority of the seeded labeled ASCs were incorporated into
the regenerated epidermis, dermis, and capillaries.
2.Materialsand Methods
2.1. Isolation of Adipose Tissue-Derived Stromal Cells from
db/db and db/+ Mice. Male mutant diabetic mice (C57BL/
ksJ db/db) and their normal littermates (db/+)( C R E AJ a p a n
Inc., Tokyo, Japan) were used. All mice were maintained on
a standard laboratory diet and water ad libitum and were
used experimentally after reaching 10 weeks of age. Prior to
the experiments, urinary glucose and protein were analyzed
using reagent strips (Uro-Labstix; BayerMedical Ltd., Tokyo,
Japan), and all of the db/db and db/+ mice were diagnosed to
be severely diabetic and normal, respectively.
Adipose tissue was obtained from the abdomens of the
db/db and db/+ mice. ASCs were prepared as described
previously [2, 3, 19]. Brieﬂy, approximately 1g of adipose
tissue from 1 db/db mouse was washed extensively with
10mL of phosphate-buﬀered saline (PBS). Similarly, 1g of
adipose tissue was prepared from the inguinal adipose tissue
of 3–10-week-old db/+ mice. The extracellular matrices were
digested with 0.075% collagenase at 37◦Cf o r1h .A f t e rt h e
addition of Dulbecco’s Modiﬁed Eagle’s Medium (DMEM)
containing 10% fetal bovine serum (FBS) and antibiotics,
the samples were centrifuged at 1,200g for 10min. The
cell pellet was resuspended in medium and incubated at
room temperature for 10min. After the cellular remains
were ﬁltered with a 100-µm nylon mesh, the cells were
resuspended with control medium, and about 5 × 105 cells
were plated into each round ACM disc (1.5cm in diameter;
PELNAC; Gunze Co., Kyoto, Japan). The ACM containing
the ASCs was incubated in control medium at 37◦Cf o r
2h before transplantation. The yield of adhered ASCs was
estimated to be about 4 × 105 to 6 × 105 cells per gram of
adipose tissue obtained from both db/db and db/+ mice.
2.2. Monolayer Culture of ASCs and Immunohistochemistry.
After the removal of cellular remains through a 100-µm
nylon mesh, ASCs were incubated in DMEM containing
10% FBS and antibiotics in a dish (100mm in diameter).
When the adhered cells became subconﬂuent after 4 days of
culture, they were subcultured. For the in vitro experiments,
the cells were released from the culture dish by treatment
with a trypsin-EDTA solution (1×;0 . 2 gE D T Aa n d0 . 5 g
porcine trypsin per liter of HBSS; Sigma Aldrich Japan,
Tokyo) at 37 ◦Cfor5min,andthesuspensionwascentrifuged
to pellet the cells. The cells were then resuspended in DMEM
containing 10% FBS and antibiotics and used as ASCs.
ASCs from db/db and db/+ mice were cultured for 4 days
in DMEM containing 10% FBS and antibiotics to an almost
conﬂuent monolayer. The cultures were washed with PBS
and ﬁxed for 30min in a solution of 2% paraformaldehyde
and 0.5% glutaraldehyde, followed by a wash with PBS. The
culture plates were then incubated with primary polyclonal
antibody (antimouse/rabbit Type I collagen; Cosmo Bio
Co. Ltd., Tokyo, Japan) at room temperature for 1h and
with secondary antibody (goat antirabbit biotinylated anti-
IgG; Cosmo Bio Co. Ltd.) for 30min, followed by a wash
with PBS. The primary antibody was then visualized with
ABC-peroxidase reagent and Novared substrate, according
to the manufacturer’s instructions (Vector Laboratories,
Peterborough, UK), and the culture plates were examined
under a light microscope (Leica DM-IRB (SLR); Leica
Microsystems, Tokyo, Japan).
2.3. Quantiﬁcation of Growth Factor and Cytokines. ASCs
from db/db and db/+ mice were plated on 10-cm-diameter
plastic dishes (1 × 106 cells per dish). ASC-conditioned
medium was collected at 4 days after plating. At the end of
the culture period, supernatants were collected and stored at
−80◦Cuntil analysis. The presenceof cytokineswas analyzed
using the BioPlex system (Bio-Rad Laboratories Co. Ltd.,
Tokyo, Japan). The following cytokines were analyzed: inter-
leukin 6 (IL-6), granulocyte-macrophage colony-stimulating
factor (GM-CSF), macrophage colony-stimulating factor
(M-CSF), basic ﬁbroblast growth factor (b-FGF), platelet-
derived growth factor bb (PDGF-bb), and vascular endothe-
lial growth factor (VEGF). Hepatocyte growth factor (HGF)
levelsinthecellculturesupernatantsweremeasuredusingan
ELISA kit (Institute of Immunology Co. Ltd., Tokyo, Japan).
2.4. Fluorescent Labeling of ASCs. Isolated ASCs from db/db
mice (1 × 106 cells) were suspended in serum-free DMEM
and ﬂuorescent labeled by adding 5µL of Vybrant DiI cell-
labeling solution (Cambrex BioScience Inc., Charles City,
Iowa, USA) to the cell suspension for 20min at 37◦C,Journal of Tissue Engineering 3
according to the manufacturer’s instructions. The labeled
cells were washed, centrifuged, and resuspended in DMEM
containing antibiotics. ACMs containing labeled ASCs were
prepared and then applied to wounds, as described below.
2.5. Transplantation of ACM Containing ASCs. Under gen-
eral anesthesia with pentobarbital sodium (Dainippon Sum-
itomo Pharma Co. Ltd. Osaka, Japan), the dorsal area
was totally depilated, and 2 full-thickness round wounds
(approximately 1.5cm in diameter) were created on the back
of each db/db mouse with a pair of sharp scissors and a
scalpel. An ACM alone (control) or an ACM containing
freshly isolated ASCs was applied to the wound using 6-
O nylon sutures (Kono Seisakusho Co. Ltd., Chiba, Japan).
The skin area surrounding the wound was removed from
each db/db mouse for histological examination at 1 and 2
weeks after treatment (n = 6 for each time point). These
animal experimentswereapprovedandcarriedoutfollowing
the guidelines for animal experimentation of the National
Defense Medical College, Tokorozawa, Saitama, Japan.
2.6. Histological Examination. Removed skin samples
including wound tissue were ﬁxed in a 10% formaldehyde
solution, embedded in paraﬃn, and sectioned in 4-µm
increments (Yamato Kohki Inc., Asaka, Saitama, Japan).
Sections were made perpendicular to the anterior-posterior
axis and perpendicular to the surface of the wound and were
stained with hematoxylin-eosin reagent. For each section,
a randomized area showing granulation and capillary
formation was photographed (×100 magniﬁcation), and
the thickness of granulation formation and number of
capillary lumens per microphotograph were evaluated.
Only mature vessels containing erythrocytes were counted.
For immunohistochemistry, the frozen sections were also
immunostained with rabbit antimouse CD31 antibody
(Takara Bio Inc.).
2.7.WoundClosure Analysis. Digitalphotographsweretaken
1 and 2 weeks after the silicon membrane was removed. The
silicone membranes of the ACMs were removed after 1 week.
Wound closure was quantiﬁed by the epithelialization rate
(%), which was calculated as (1 − open wound area/original
wound area) × 100 (Table 1).
2.8. Statistical Analysis. Results are expressed as mean ±
SD. A paired Student’s t-test was used to determine the
probability of signiﬁcant diﬀerences. A value of P<. 05 was
considered to be statistically signiﬁcant.
3.Results
3.1. Expansions of ASCs from db/db and db/+ Mice and
Immunohistochemistry. After cell isolation with enzymes as
described above, more than 5 × 105 nucleated cells adhering
to the culture plates were obtained from about 1g of adipose
tissuefromdb/dbanddb/+mice.After4days,cellsfromboth
types of mice were subconﬂuent and ﬁbroblast-like. When
detached and subcultured for 3 days, the 2 groups of cells
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Figure 1:After 4daysofculture, ASCsfromdb/db(◦)anddb/+(
￿)
mice were detached with trypsin-EDTA solution and cultured for 3
days with identical growth rates.
showed identical growth rates (Figure 1). After a total of 8
days in culture (2 passages), the cells were collected and used
as ASCs; at this point, the number of ASCs was at least 25
timeshigherthanthenumberoforiginallyplatedcells.There
was no signiﬁcant diﬀerence in ASC yield between the db/db
and db/+ mice.
ASCs from db/db and db/+ mice were cultured to an
almost conﬂuent monolayer and then immunostained with
primary antibody (anti-Type I collagen). There was no
signiﬁcant diﬀerence between the cell cultures in the speciﬁc
binding of the primary antibody (Figure 2).
3.2. Quantiﬁcation of Growth Factors and Cytokines Secreted
by ASCs. Cultured ASCs from db/db and db/+ mice secreted
signiﬁcant amounts of growth factors and cytokines, includ-
ing IL-6, b-FGF, PDGF-bb, VEGF, and HGF over a 4-
day period (Figure 3). No statistically signiﬁcant diﬀerences
were observed between ASCs from db/db and db/+ mice in
the secretion of those angiogenic factors. The generation
of growth factors might be suitable for regenerative ASC
therapy for healing-impaired wounds.
3.3. Fluorescent Labeling of ASCs from db/db Mice and
Autologous Transplantation. About 25%–30% of the ASCs
isolated from db/db mice were labeled with DiI (Figure 4(a)).
ACMs containing labeled ASCswere prepared and appliedto
wounds (n = 6) (Figure 4(b)). Figures 5(a) and 5(b) show
CD31-immunostaining and DiI-labeled tissue, respectively,
on the transplant area of db/db mice at 2 weeks. The trans-
planted DiI-labeled ASCs were mainly incorporated into
regenerated granulation and epithelial tissues (Figure 5(b)).
Some microvessels were double-labeled with ﬂuorescence
(DiI) and CD 31 (Figure 5(c)), suggesting that some of
the seeded ASCs may incorporate into blood vessels as
endothelial-progenitor cells.
3.4. Observations on Transplantation of ACM Containing
Autologous ASCs. We observed no signs of undesirable4 Journal of Tissue Engineering
Table 1: Eﬀects of ASCs-containingACM on wound healing of db/db mice.
Control (ACM alone) ASCs-containing ACM
db/+ mice db/db mice db/+ mice db/db mice
Granulation tissue thickness (µm)
1 week 745.0 ± 105.0 160.2 ± 26.0 762.0 ± 121.0 236.9 ± 35.8∗
2 weeks Not determined 290.5 ± 42.0 Not determined 806.7 ± 124.0∗∗
Vessels (per sight)
1 week 44 ± 17 17 ± 44 7 ± 18 32 ± 14∗
2 weeks Not determined 23 ± 5N o t d e t e r m i n e d5 5 ± 16∗∗
Epithelialization rates (Wound closure) (%)
1 week 90.5 ± 5.0 14.8 ± 8.4 93.6 ± 4.8 16.8 ± 9.8
2 weeks Not determined 52.6 ± 11.8 Not determined 87.3 ± 5.1∗∗
Epithelialization rates (%) were calculated by the equation “(1 − open wound area/original wound area) × 100.” Data represent mean ± SD. Student’s t test
∗P<. 05,∗∗P<. 001.
db/+ mouse-derived ASCs
(a)
db/db mouse-derived ASCs
(b)
Figure 2: Photographs are representative of 6 wounds treated with ACM alone or with ACM containing ASCs immunostained with anti-
Type I collagen.
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Figure 3: Growth factors and cytokines present in cell culture
supernatants were analyzed on day 4 in ASCs from db/+ (white
bars) and db/db (black bars) mice. Data represent the mean ± SD
of duplicate samples from 3 culture supernatants.
inﬂammation, infection, neovascularization, or adipose tis-
sue formation in wounds treated with ACM alone or with
ACM containing ASCs. Wound areas were recorded with the
aid of a digital camera at 1 and 2 weeks (Figure 6). Although
wound closures (epithelialization rates) did not appear to be
stimulatedinthewoundstreatedwithACMcontainingASCs
at 1 week, there was signiﬁcantly enhanced wound closure at
2 weeks, compared with the control (ACM alone) wounds
(Table 1).
3.5. Granulation Tissue Thickness and Capillary Number.
Signiﬁcant stimulation of granulation tissue formation was
observed in the ACM containing ASCs at 1 and 2 weeks
(Table 1). Signiﬁcant stimulatory eﬀects on capillary for-
mation were also seen in the wounds treated with ACM
containing ASCs at 1 and 2 weeks (Table 1). When the eﬀects
of treatment with ACM alone or ACM containing ASCs
were assessed in the wounds of db/+ mice, no statistically
signiﬁcant diﬀerences were observed regarding granulation,
epithelial,andcapillary formation;bothwoundswerealmost
repaired after 1 week (Table 1).
4.Discussion
Other researchers and we have previously reported that
stromal cells derived from adipose tissue possess the abil-
ity to produce cartilage and bone matrix [1–3]. LargeJournal of Tissue Engineering 5
(a) (b)
Figure 4: Labeling eﬃciency of Vybrant DiI-labeled ASCs isolated from db/db mice was about 25–30% (a). ACMs containing Dil-labeled
ASCs were then prepared and applied to the wounds of db/db mice (b).
(a) (b)
(c)
Figure5:CD31-immunostained(a)andDiI-labeled (b)tissueonthetransplantareasofdb/dbmiceat2weeks.The transplantedDiI-labeled
ASCs were mainlyincorporated into regenerated granulationand epithelial tissues.Somemicrovessels were double-labeled with DiI andCD
31 (c). Each photograph is representative of 6 experiments.
quantities of ASCs can be obtained from human adi-
pose tissue by liposuction under local anesthesia; thus,
cell multiplication under expensive and laborious cell-
culture conditions is not required. Approximately 5 × 105
cells per gram of adipose tissue can be obtained from
human adipose tissue by liposuction (data not shown).
In contrast to a cultured dermal substitute, our ACM
containing ASCs can be prepared within a few hours
in a clinical setting. Furthermore, the use of autologous
ASCs reduces the risks of infectious disease transmission
and cellular rejection. Thus, ASCs represent an abundant,
safe, practical, and appealing source for autologous cell
replacement.
In this study, ASCs from db/db and db/+ mice pro-
liferated for 3 days with identical growth rates. There
was no signiﬁcant diﬀerence in the production of Type I
collagenbetween the cell culturesfrom db/db and db/+ mice.
Furthermore, ASCs from db/db and db/+ mice both showed
high levels of CD34 and Sca1 but not of c-kit (data not
shown), suggesting that the 2 sets of ASCs include similar6 Journal of Tissue Engineering
ACMC
alone
ASCs-containing
ACMC
100µm 100µm
5mm 5mm
2weeks
Figure 6: ACM containing ASCs or ACM alone was applied to
each wound by suture. The silicon membranes were removed at 1
week; the skin surrounding the wounds was removed at 2 weeks
and sectioned for histological examination. Sections were made
perpendicular to the wound surface. Histological examination of
wound repair was performed at 2 weeks after the initial wounding.
Photographs are representative of 6 wounds treated with ACM
aloneand 6wounds treated withACM containingASCs.Tissuewas
stained with hematoxylin-eosin. Short arrows show blood vessels
containing erythrocytes. Long arrows show the thickness of the
granulation tissue.
populations of mesenchymal stem cells from bone marrow
[21, 22].
Cultured ASCs from db/db and db/+ mice secreted a
number of angiogenic cytokines—including b-FGF, PDGF-
bb, VEGF, and HGF—at similar, bioactive levels. Introduc-
tionofASCsin vivomightalsoupregulateexpressionofthese
growth factors by autocrine and/or paracrine actions in the
wound [23].
By using ﬂuorescent (DiI) labeling of ASCs from db/db
mice and autologous transplantation, we investigated the
fates of autologous ASCs seeded into healing-impaired
wounds, the diﬀerentiation of autologous ASCs, and the
interactions between seeded autologous ASCs and their
environment. The results suggested that the majority of
seeded autologous ASCs were incorporated into the regen-
erated granulation and epithelial tissues. In addition, some
of the seeded ASCs may incorporate into blood vessels as
endothelial-progenitorcells[24].In fact,applicationofASCs
hasbeensuggestedashavingpotentialforangiogenictherapy
for ischemic disease [21].
The application of ACM alone to an open wound in
db/db mice resulted in minor eﬀects on granulation tissue
formation, epithelialization, and capillary number. However,
parameters such as granulation tissue thickness, epithelium,
and vessel formation were signiﬁcantly increased in the
wounds treated with ACM containing autologous ASCs at
1 or 2 weeks in the db/db mice. Although the mechanism
responsible for impaired wound healing in db/db mice
is not completely understood [12], it is likely that the
presence of macrophages has a signiﬁcant eﬀect on the
formation of wound granulation tissue and that macrophage
accumulationis impaired indb/db mice [12].Furthermore, a
defect in the expression of vascular endothelial growth factor
may be associated with any wound-healing disorder [13].
It is interesting to note that the addition of autologous
ASCs into the ACM had only minor eﬀects on the degree
of healing in normal (db/+)m i c e .A se x p l a i n e da b o v e ,
macrophages have a signiﬁcant eﬀect on the formation of
wound granulation tissue [12]; it is likely that suﬃcient
macrophages accumulate in db/+ mice but not in db/db
mice. Thus, it is possible that db/+ mice have a suﬃcient
amount of growth factors in the wound and wound ﬂuid to
permitamaximalrateofhealing, and therefore, onlya minor
increase in wound repair can result from the application of
autologous ASCs. In addition, the wound closure assay and
histological examinations used in this study might not be
sensitive enough to detect small eﬀects.
5.Conclusion
ASCs from both db/db and db/+ mice proliferated with
identical growth rates, produced Type I collagen, and
secreted a number of angiogenic cytokines at similar levels.
Wound healing experiments using the db/db mouse model
showed that the application of ACM containing autologous
ASCs onto an open wound induced the formation of
signiﬁcant granulation tissue, epithelium, and capillaries,
thereby accelerating wound healing.
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